Cardiorenal Outcomes with Ertugliflozin by Baseline Cardiorenal Medications: An Analysis from VERTIS CV

被引：0
|
作者：
Cherney, David
Cosentino, Francesco
Mcguire, Darren K.
Charbonnel, Bernard
Dagogo-Jack, Samuel
Pratley, Richard E.
Shih, Weichung J.
Maldonado, Mario
Pong, Annpey
Gantz, Ira
Frederich, Robert
Mancuso, James P.
Masiukiewicz, Urszula
Cannon, Christopher P.
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-796-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
796-P
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Cardiorenal outcomes with ertugliflozin by baseline cardiorenal medications: an analysis from VERTIS CV
    Cannon, C. P.
    Cosentino, F.
    McGuire, D. K.
    Charbonnel, B.
    Dagogo-Jack, S.
    Pratley, R. E.
    Shih, W. J.
    Maldonado, M.
    Pong, A.
    Gantz, I.
    Frederich, R.
    Mancuso, J. P.
    Masiukiewicz, U.
    Cherney, D. Z. I.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 29 - 30
  • [2] Cardiorenal outcomes with ertugliflozin by baseline glucose-lowering agent: an analysis from VERTIS CV
    Charbonnel, B.
    Dagogo-Jack, S.
    Cannon, C. P.
    Cherney, D. Z. I.
    Cosentino, F.
    McGuire, D. K.
    Shih, W. J.
    Liu, J.
    Pong, A.
    Gantz, I.
    Frederich, R.
    Mancuso, J. P.
    Pratley, R. E.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 226 - 226
  • [3] Cardiorenal Outcomes with Ertugliflozin by Baseline (BL) Glucose Lowering Agent (GLA): An Analysis from VERTIS CV
    Charbonnel, Bernard
    Dagogo-Jack, Samuel
    Cannon, Christopher P.
    Cherney, David
    Cosentino, Francesco
    Mcguire, Darren K.
    Shih, Weichung J.
    Liu, Jie
    Pong, Annpey
    Gantz, Ira
    Frederich, Robert
    Mancuso, James P.
    Pratley, Richard E.
    [J]. DIABETES, 2021, 70
  • [4] Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose-lowering agent: An analysis from VERTIS CV
    Dagogo-Jack, Samuel
    Cannon, Christopher P.
    Cherney, David Z., I
    Cosentino, Francesco
    Liu, Jie
    Pong, Annpey
    Gantz, Ira
    Frederich, Robert
    Mancuso, James P.
    Pratley, Richard E.
    [J]. DIABETES OBESITY & METABOLISM, 2022, 24 (07): : 1245 - 1254
  • [5] Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial
    Cosentino, Francesco
    Cannon, Christopher P.
    Frederich, Robert
    Cherney, David Z. I.
    Dagogo-Jack, Samuel
    Pratley, Richard E.
    Mancuso, James P.
    Maldonado, Mario
    Cater, Nilo B.
    Wang, Shuai
    McGuire, Darren K.
    [J]. CIRCULATION, 2022, 146 (08) : 652 - 654
  • [6] Cardiorenal outcomes with ertugliflozin by baseline metformin use: post-hoc analyses of the VERTIS CV trial
    Cosentino, F.
    Cannon, C. P.
    Cherney, D. Z. I.
    Dagogo-Jack, S.
    Pratley, R. E.
    Charbonnel, B.
    Shih, W. J.
    Mancuso, J. P.
    Maldonado, M.
    Frederich, R.
    Cater, N. B.
    Wang, S.
    McGuire, D. K.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 2650 - 2650
  • [7] Cardiorenal outcomes, kidney function, and other safety outcomes with ertugliflozin in older adults with type 2 diabetes (VERTIS CV): secondary analyses from a randomised, double-blind trial
    Pratley, Richard E.
    Cannon, Christopher P.
    Cherney, David Z., I
    Cosentino, Francesco
    McGuire, Darren K.
    Essex, Margaret Noyes
    Lawrence, David
    Jones, Philip L. S.
    Liu, Jie
    Adamsons, Ingrid
    Dagogo-Jack, Samuel
    [J]. LANCET HEALTHY LONGEVITY, 2023, 4 (04): : E143 - E154
  • [8] Effects of Ertugliflozin on Kidney Outcomes in Patients With Heart Failure at Baseline in the Evaluation of Ertugliflozin Efficacy and Safety Cardiovascular Outcomes (VERTIS CV) Trial
    Cherney, David Z. I.
    Cosentino, Francesco
    McGuire, Darren K.
    Kolkailah, Ahmed A.
    Dagogo-Jack, Samuel
    Pratley, Richard E.
    Frederich, Robert
    Maldonado, Mario
    Liu, Chih-Chin
    Cannon, Christopher P.
    [J]. KIDNEY INTERNATIONAL REPORTS, 2023, 8 (04): : 746 - 753
  • [9] Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)
    Cannon, Christopher P.
    Mcguire, Darren K.
    Pratley, Richard
    Dagogo-Jack, Sam
    Mancuso, James
    Huyck, Susan
    Charbonnel, Bernard
    Shih, Weichung J.
    Gallo, Silvina
    Masiukiewicz, Urszula
    Golm, Gregory
    Cosentino, Francesco
    Lauring, Brett
    Terra, Steven G.
    [J]. AMERICAN HEART JOURNAL, 2018, 206 : 11 - 23
  • [10] Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)
    McGuire, D. K.
    Cannon, C. P.
    Pratley, R.
    Dagogo-Jack, S.
    Mancuso, J.
    Huyck, S.
    Charbonnel, B.
    Shih, W. J.
    Gallo, S.
    Masiukiewicz, U.
    Golm, G.
    Cosentino, F.
    Lauring, B.
    Terra, S. G.
    [J]. DIABETOLOGIA, 2018, 61 : S305 - S306
12345